Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Po-Han Wu
Downregulation of miR-199a/b-5p Is Associated With GCNT2 Induction Upon Epithelial-Mesenchymal Transition in Colon Cancer
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
CDC42 Regulates the Expression of Superficial Zone Molecules in Part Through the Actin Cytoskeleton and Myocardin-Related Transcription Factor-A
Journal of Orthopaedic Research
Orthopedics
Sports Medicine
Related publications
Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial–Mesenchymal Transition and Stemness in Esophageal Carcinoma
Cells
miR-125a-5p Inhibits Colorectal Cancer Cell Epithelial–mesenchymal Transition, Invasion and Migration by Targeting TAZ
OncoTargets and Therapy
Oncology
Pharmacology
TAZ Overexpression Is Associated With Epithelial-Mesenchymal Transition in Cisplatin-Resistant Gastric Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis
International Journal of Oncology
Cancer Research
Oncology
Cisplatin Resistance in Gastric Cancer Cells Is Associated With HER2 Upregulation-Induced Epithelial-Mesenchymal Transition
Scientific Reports
Multidisciplinary
Downregulation of miR-218 Contributes to Epithelial–mesenchymal Transition and Tumor Metastasis in Lung Cancer by Targeting Slug/Zeb2 Signaling
Oncogene
Cancer Research
Genetics
Molecular Biology
miR-431-5p Alters the Epithelial-To-Mesenchymal Transition Markers by Targeting UROC28 in Hepatoma Cells
OncoTargets and Therapy
Oncology
Pharmacology
miR-15b Promotes Epithelial-Mesenchymal Transition by Inhibiting SMURF2 in Pancreatic Cancer
International Journal of Oncology
Cancer Research
Oncology
